IMMUNE PHARMACEUTICALS INC 4
4 · IMMUNE PHARMACEUTICALS INC · Filed Nov 23, 2015
Insider Transaction Report
Form 4
Luchi Monica E.
EVP & CMO
Transactions
- Award
Stock Option
2015-11-19+400,000→ 400,000 totalExercise: $0.98Exp: 2025-11-19→ Common Stock (400,000 underlying)
Footnotes (2)
- [F1]The stock options shall vest over a period of three years, with 1/3 of the options vesting on the first anniversary of the date of grant and the remainder vesting quarterly over the following two-year period.
- [F2]The stock options were granted as an inducement grant pursuant to NASDAQ Listing Rule 5635(c)(4) in connection with the reporting person's appointment as EVP, Global Drug Development and Chief Medical Officer.